<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-11-01" modified="2020-04-22" version="247">
<accession>P05556</accession>
<accession>A8K6N2</accession>
<accession>D3DRX9</accession>
<accession>D3DRY3</accession>
<accession>D3DRY4</accession>
<accession>D3DRY5</accession>
<accession>P78466</accession>
<accession>P78467</accession>
<accession>Q13089</accession>
<accession>Q13090</accession>
<accession>Q13091</accession>
<accession>Q13212</accession>
<accession>Q14622</accession>
<accession>Q14647</accession>
<accession>Q29RW2</accession>
<accession>Q7Z3V1</accession>
<accession>Q8WUM6</accession>
<name>ITB1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Integrin beta-1</fullName>
</recommendedName>
<alternativeName>
<fullName>Fibronectin receptor subunit beta</fullName>
</alternativeName>
<alternativeName>
<fullName>Glycoprotein IIa</fullName>
<shortName>GPIIA</shortName>
</alternativeName>
<alternativeName>
<fullName>VLA-4 subunit beta</fullName>
</alternativeName>
<cdAntigenName>CD29</cdAntigenName>
</protein>
<gene>
<name type="primary">ITGB1</name>
<name type="synonym">FNRB</name>
<name type="synonym">MDF2</name>
<name type="synonym">MSK12</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="J. Cell Biol." volume="105" first="1183" last="1190">
<title>Amino acid sequence of the human fibronectin receptor.</title>
<authorList>
<person name="Argraves W.S."/>
<person name="Suzuki S."/>
<person name="Arai H."/>
<person name="Thompson K."/>
<person name="Pierschbacher M.D."/>
<person name="Ruoslahti E."/>
</authorList>
<dbReference type="PubMed" id="2958481"/>
<dbReference type="DOI" id="10.1083/jcb.105.3.1183"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Endometrium</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="J. Cell Biol." volume="121" first="171" last="178">
<title>Expression and functional analysis of a cytoplasmic domain variant of the beta 1 integrin subunit.</title>
<authorList>
<person name="Balzac F."/>
<person name="Belkin A.M."/>
<person name="Koteliansky V.E."/>
<person name="Balabanov Y.V."/>
<person name="Altruda F."/>
<person name="Silengo L."/>
<person name="Tarone G."/>
</authorList>
<dbReference type="PubMed" id="7681433"/>
<dbReference type="DOI" id="10.1083/jcb.121.1.171"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 717-757</scope>
<scope>CHARACTERIZATION OF BETA-1B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Cell Biol." volume="127" first="557" last="565">
<title>Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility.</title>
<authorList>
<person name="Balzac F."/>
<person name="Retta S.F."/>
<person name="Albini A."/>
<person name="Melchiorri A."/>
<person name="Koteliansky V.E."/>
<person name="Geuna M."/>
<person name="Silengo L."/>
<person name="Tarone G."/>
</authorList>
<dbReference type="PubMed" id="7523423"/>
<dbReference type="DOI" id="10.1083/jcb.127.2.557"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 717-757</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Gene" volume="95" first="261" last="266">
<title>A human integrin beta 1 subunit with a unique cytoplasmic domain generated by alternative mRNA processing.</title>
<authorList>
<person name="Altruda F."/>
<person name="Cervella P."/>
<person name="Tarone G."/>
<person name="Botta C."/>
<person name="Balzac F."/>
<person name="Stefanuto G."/>
<person name="Silengo L."/>
</authorList>
<dbReference type="PubMed" id="2249781"/>
<dbReference type="DOI" id="10.1016/0378-1119(90)90369-3"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="7116" last="7120">
<title>An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain.</title>
<authorList>
<person name="Languino L.R."/>
<person name="Ruoslahti E."/>
</authorList>
<dbReference type="PubMed" id="1551917"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="Biochem. Biophys. Res. Commun." volume="214" first="279" last="285">
<title>Novel isoform of beta 1 integrin expressed in skeletal and cardiac muscle.</title>
<authorList>
<person name="Zhidkova N.I."/>
<person name="Belkin A.M."/>
<person name="Mayne R."/>
</authorList>
<dbReference type="PubMed" id="7545396"/>
<dbReference type="DOI" id="10.1006/bbrc.1995.2285"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="FEBS Lett." volume="369" first="340" last="344">
<title>A novel beta 1 integrin isoform produced by alternative splicing: unique expression in cardiac and skeletal muscle.</title>
<authorList>
<person name="van der Flier A."/>
<person name="Kuikman I."/>
<person name="Baudoin C."/>
<person name="van der Neut R."/>
<person name="Sonnenberg A."/>
</authorList>
<dbReference type="PubMed" id="7544298"/>
<dbReference type="DOI" id="10.1016/0014-5793(95)00814-p"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Biochem. J." volume="330" first="1255" last="1263">
<title>Identification of beta1C-2, a novel variant of the integrin beta1 subunit generated by utilization of an alternative splice acceptor site in exon C.</title>
<authorList>
<person name="Svineng G."/>
<person name="Faessler R."/>
<person name="Johansson S."/>
</authorList>
<dbReference type="PubMed" id="9494094"/>
<dbReference type="DOI" id="10.1042/bj3301255"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Biochim. Biophys. Acta" volume="1689" first="175" last="178">
<title>Interaction of ACE2 and integrin beta1 in failing human heart.</title>
<authorList>
<person name="Lin Q."/>
<person name="Keller R.S."/>
<person name="Weaver B."/>
<person name="Zisman L.S."/>
</authorList>
<dbReference type="PubMed" id="15276642"/>
<dbReference type="DOI" id="10.1016/j.bbadis.2004.05.005"/>
</citation>
<scope>PROTEIN SEQUENCE OF 775-784 (ISOFORM 5)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH ACE2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="J. Virol." volume="67" first="6847" last="6852">
<title>Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2.</title>
<authorList>
<person name="Bergelson J.M."/>
<person name="St John N."/>
<person name="Kawaguchi S."/>
<person name="Chan M."/>
<person name="Stubdal H."/>
<person name="Modlin J."/>
<person name="Finberg R.W."/>
</authorList>
<dbReference type="PubMed" id="8411387"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HUMAN ECHOVIRUS 1 AND HUMAN ECHOVIRUS 8 CAPSID PROTEINS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="J. Cell Biol." volume="132" first="211" last="226">
<title>Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells.</title>
<authorList>
<person name="Belkin A.M."/>
<person name="Zhidkova N.I."/>
<person name="Balzac F."/>
<person name="Altruda F."/>
<person name="Tomatis D."/>
<person name="Maier A."/>
<person name="Tarone G."/>
<person name="Koteliansky V.E."/>
<person name="Burridge K."/>
</authorList>
<dbReference type="PubMed" id="8567725"/>
<dbReference type="DOI" id="10.1083/jcb.132.1.211"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="1606" last="1613">
<title>Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.</title>
<authorList>
<person name="Sasaki T."/>
<person name="Brakebusch C."/>
<person name="Engel J."/>
<person name="Timpl R."/>
</authorList>
<dbReference type="PubMed" id="9501082"/>
<dbReference type="DOI" id="10.1093/emboj/17.6.1606"/>
</citation>
<scope>INTERACTION WITH LGALS3BP</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Blood" volume="94" first="663" last="672">
<title>The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.</title>
<authorList>
<person name="Barillari G."/>
<person name="Sgadari C."/>
<person name="Fiorelli V."/>
<person name="Samaniego F."/>
<person name="Colombini S."/>
<person name="Manzari V."/>
<person name="Modesti A."/>
<person name="Nair B.C."/>
<person name="Cafaro A."/>
<person name="Stuerzl M."/>
<person name="Ensoli B."/>
</authorList>
<dbReference type="PubMed" id="10397733"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HIV-1 TAT</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="24947" last="24952">
<title>A novel protease-docking function of integrin at invadopodia.</title>
<authorList>
<person name="Mueller S.C."/>
<person name="Ghersi G."/>
<person name="Akiyama S.K."/>
<person name="Sang Q.X."/>
<person name="Howard L."/>
<person name="Pineiro-Sanchez M."/>
<person name="Nakahara H."/>
<person name="Yeh Y."/>
<person name="Chen W.T."/>
</authorList>
<dbReference type="PubMed" id="10455171"/>
<dbReference type="DOI" id="10.1074/jbc.274.35.24947"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH FAP</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="J. Cell Biol." volume="147" first="1391" last="1398">
<title>A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation.</title>
<authorList>
<person name="Li J."/>
<person name="Mayne R."/>
<person name="Wu C."/>
</authorList>
<dbReference type="PubMed" id="10613898"/>
<dbReference type="DOI" id="10.1083/jcb.147.7.1391"/>
</citation>
<scope>INTERACTION WITH NMRK2</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="2953" last="2960">
<title>Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.</title>
<authorList>
<person name="Zhang J."/>
<person name="Clatterbuck R.E."/>
<person name="Rigamonti D."/>
<person name="Chang D.D."/>
<person name="Dietz H.C."/>
</authorList>
<dbReference type="PubMed" id="11741838"/>
<dbReference type="DOI" id="10.1093/hmg/10.25.2953"/>
</citation>
<scope>INTERACTION WITH ITGB1BP1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="20895" last="20902">
<title>Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement.</title>
<authorList>
<person name="Fournier H.N."/>
<person name="Dupe-Manet S."/>
<person name="Bouvard D."/>
<person name="Lacombe M.L."/>
<person name="Marie C."/>
<person name="Block M.R."/>
<person name="Albiges-Rizo C."/>
</authorList>
<dbReference type="PubMed" id="11919189"/>
<dbReference type="DOI" id="10.1074/jbc.m200200200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="361" last="376">
<title>Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin (beta) subunits.</title>
<authorList>
<person name="van Der Flier A."/>
<person name="Kuikman I."/>
<person name="Kramer D."/>
<person name="Geerts D."/>
<person name="Kreft M."/>
<person name="Takafuta T."/>
<person name="Shapiro S.S."/>
<person name="Sonnenberg A."/>
</authorList>
<dbReference type="PubMed" id="11807098"/>
<dbReference type="DOI" id="10.1083/jcb.200103037"/>
</citation>
<scope>INTERACTION WITH FLNA AND FLNB</scope>
<scope>MUTAGENESIS OF GLY-778 AND ALA-786</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="377" last="387">
<title>The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading.</title>
<authorList>
<person name="Degani S."/>
<person name="Balzac F."/>
<person name="Brancaccio M."/>
<person name="Guazzone S."/>
<person name="Retta S.F."/>
<person name="Silengo L."/>
<person name="Eva A."/>
<person name="Tarone G."/>
</authorList>
<dbReference type="PubMed" id="11807099"/>
<dbReference type="DOI" id="10.1083/jcb.200108030"/>
</citation>
<scope>INTERACTION WITH ITGB1BP1</scope>
<scope>MUTAGENESIS OF 786-ALA--VAL-791</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Blood" volume="102" first="3927" last="3933">
<title>Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.</title>
<authorList>
<person name="Weigel-Kelley K.A."/>
<person name="Yoder M.C."/>
<person name="Srivastava A."/>
</authorList>
<dbReference type="PubMed" id="12907437"/>
<dbReference type="DOI" id="10.1182/blood-2003-05-1522"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HUMAN PARVOVIRUS B19 CAPSID PROTEIN</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6567" last="6574">
<title>Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1 alpha.</title>
<authorList>
<person name="Bouvard D."/>
<person name="Vignoud L."/>
<person name="Dupe-Manet S."/>
<person name="Abed N."/>
<person name="Fournier H.N."/>
<person name="Vincent-Monegat C."/>
<person name="Retta S.F."/>
<person name="Fassler R."/>
<person name="Block M.R."/>
</authorList>
<dbReference type="PubMed" id="12473654"/>
<dbReference type="DOI" id="10.1074/jbc.m211258200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ITGB1BP1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="24200" last="24208">
<title>CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.</title>
<authorList>
<person name="Lin C.G."/>
<person name="Leu S.J."/>
<person name="Chen N."/>
<person name="Tebeau C.M."/>
<person name="Lin S.X."/>
<person name="Yeung C.Y."/>
<person name="Lau L.F."/>
</authorList>
<dbReference type="PubMed" id="12695522"/>
<dbReference type="DOI" id="10.1074/jbc.m302028200"/>
</citation>
<scope>INTERACTION WITH CCN3</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="34605" last="34616">
<title>Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins.</title>
<authorList>
<person name="Bax D.V."/>
<person name="Bernard S.E."/>
<person name="Lomas A."/>
<person name="Morgan A."/>
<person name="Humphries J."/>
<person name="Shuttleworth C.A."/>
<person name="Humphries M.J."/>
<person name="Kielty C.M."/>
</authorList>
<dbReference type="PubMed" id="12807887"/>
<dbReference type="DOI" id="10.1074/jbc.m303159200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBN1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="J. Virol." volume="77" first="9969" last="9978">
<title>Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry.</title>
<authorList>
<person name="Graham K.L."/>
<person name="Halasz P."/>
<person name="Tan Y."/>
<person name="Hewish M.J."/>
<person name="Takada Y."/>
<person name="Mackow E.R."/>
<person name="Robinson M.K."/>
<person name="Coulson B.S."/>
</authorList>
<dbReference type="PubMed" id="12941907"/>
<dbReference type="DOI" id="10.1128/jvi.77.18.9969-9978.2003"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HUMAN ROTAVIRUS VP4 PROTEIN</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="13027" last="13034">
<title>RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1.</title>
<authorList>
<person name="Denti S."/>
<person name="Sirri A."/>
<person name="Cheli A."/>
<person name="Rogge L."/>
<person name="Innamorati G."/>
<person name="Putignano S."/>
<person name="Fabbri M."/>
<person name="Pardi R."/>
<person name="Bianchi E."/>
</authorList>
<dbReference type="PubMed" id="14722085"/>
<dbReference type="DOI" id="10.1074/jbc.m313515200"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="J. Cell Sci." volume="117" first="5405" last="5415">
<title>alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor.</title>
<authorList>
<person name="Muramatsu H."/>
<person name="Zou P."/>
<person name="Suzuki H."/>
<person name="Oda Y."/>
<person name="Chen G.Y."/>
<person name="Sakaguchi N."/>
<person name="Sakuma S."/>
<person name="Maeda N."/>
<person name="Noda M."/>
<person name="Takada Y."/>
<person name="Muramatsu T."/>
</authorList>
<dbReference type="PubMed" id="15466886"/>
<dbReference type="DOI" id="10.1242/jcs.01423"/>
</citation>
<scope>INTERACTION WITH MDK</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Mol. Biol. Cell" volume="15" first="3580" last="3590">
<title>NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin.</title>
<authorList>
<person name="Fukushi J."/>
<person name="Makagiansar I.T."/>
<person name="Stallcup W.B."/>
</authorList>
<dbReference type="PubMed" id="15181153"/>
<dbReference type="DOI" id="10.1091/mbc.e04-03-0236"/>
</citation>
<scope>INTERACTION WITH ITGA3; LGALS3 AND CSPG4</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="523" last="531">
<title>Myosin-X provides a motor-based link between integrins and the cytoskeleton.</title>
<authorList>
<person name="Zhang H."/>
<person name="Berg J.S."/>
<person name="Li Z."/>
<person name="Wang Y."/>
<person name="Lang P."/>
<person name="Sousa A.D."/>
<person name="Bhaskar A."/>
<person name="Cheney R.E."/>
<person name="Stromblad S."/>
</authorList>
<dbReference type="PubMed" id="15156152"/>
<dbReference type="DOI" id="10.1038/ncb1136"/>
</citation>
<scope>INTERACTION WITH MYO10</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Dev. Cell" volume="9" first="663" last="673">
<title>Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration.</title>
<authorList>
<person name="Li J."/>
<person name="Ballif B.A."/>
<person name="Powelka A.M."/>
<person name="Dai J."/>
<person name="Gygi S.P."/>
<person name="Hsu V.W."/>
</authorList>
<dbReference type="PubMed" id="16256741"/>
<dbReference type="DOI" id="10.1016/j.devcel.2005.09.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="J. Cell Sci." volume="118" first="3739" last="3749">
<title>The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.</title>
<authorList>
<person name="Gontier Y."/>
<person name="Taivainen A."/>
<person name="Fontao L."/>
<person name="Sonnenberg A."/>
<person name="van der Flier A."/>
<person name="Carpen O."/>
<person name="Faulkner G."/>
<person name="Borradori L."/>
</authorList>
<dbReference type="PubMed" id="16076904"/>
<dbReference type="DOI" id="10.1242/jcs.02484"/>
</citation>
<scope>INTERACTION WITH FLNB AND FLNC</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-406</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="J. Cell Biol." volume="173" first="767" last="780">
<title>Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins.</title>
<authorList>
<person name="Pellinen T."/>
<person name="Arjonen A."/>
<person name="Vuoriluoto K."/>
<person name="Kallio K."/>
<person name="Fransen J.A.M."/>
<person name="Ivaska J."/>
</authorList>
<dbReference type="PubMed" id="16754960"/>
<dbReference type="DOI" id="10.1083/jcb.200509019"/>
</citation>
<scope>INTERACTION WITH RAB21</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="J. Virol." volume="80" first="2760" last="2770">
<title>Beta1 integrin mediates internalization of mammalian reovirus.</title>
<authorList>
<person name="Maginnis M.S."/>
<person name="Forrest J.C."/>
<person name="Kopecky-Bromberg S.A."/>
<person name="Dickeson S.K."/>
<person name="Santoro S.A."/>
<person name="Zutter M.M."/>
<person name="Nemerow G.R."/>
<person name="Bergelson J.M."/>
<person name="Dermody T.S."/>
</authorList>
<dbReference type="PubMed" id="16501085"/>
<dbReference type="DOI" id="10.1128/jvi.80.6.2760-2770.2006"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH MAMMALIAN REOVIRUS CAPSID PROTEINS</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Biochem. Soc. Trans." volume="35" first="1292" last="1294">
<title>Interaction of integrin beta1 with cytokeratin 1 in neuroblastoma NMB7 cells.</title>
<authorList>
<person name="Chuang N.N."/>
<person name="Huang C.C."/>
</authorList>
<dbReference type="PubMed" id="17956333"/>
<dbReference type="DOI" id="10.1042/bst0351292"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KRT1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Dev. Cell" volume="13" first="496" last="510">
<title>Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.</title>
<authorList>
<person name="Caswell P.T."/>
<person name="Spence H.J."/>
<person name="Parsons M."/>
<person name="White D.P."/>
<person name="Clark K."/>
<person name="Cheng K.W."/>
<person name="Mills G.B."/>
<person name="Humphries M.J."/>
<person name="Messent A.J."/>
<person name="Anderson K.I."/>
<person name="McCaffrey M.W."/>
<person name="Ozanne B.W."/>
<person name="Norman J.C."/>
</authorList>
<dbReference type="PubMed" id="17925226"/>
<dbReference type="DOI" id="10.1016/j.devcel.2007.08.012"/>
</citation>
<scope>INTERACTION WITH RAB25</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="6743" last="6751">
<title>alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative studies of molecular determinants underlying integrin-rgd affinity and specificity.</title>
<authorList>
<person name="Jovanovic J."/>
<person name="Takagi J."/>
<person name="Choulier L."/>
<person name="Abrescia N.G."/>
<person name="Stuart D.I."/>
<person name="van der Merwe P.A."/>
<person name="Mardon H.J."/>
<person name="Handford P.A."/>
</authorList>
<dbReference type="PubMed" id="17158881"/>
<dbReference type="DOI" id="10.1074/jbc.m607008200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Dev. Cell" volume="15" first="371" last="385">
<title>Integrin trafficking regulated by Rab21 is necessary for cytokinesis.</title>
<authorList>
<person name="Pellinen T."/>
<person name="Tuomi S."/>
<person name="Arjonen A."/>
<person name="Wolf M."/>
<person name="Edgren H."/>
<person name="Meyer H."/>
<person name="Grosse R."/>
<person name="Kitzing T."/>
<person name="Rantala J.K."/>
<person name="Kallioniemi O."/>
<person name="Faessler R."/>
<person name="Kallio M."/>
<person name="Ivaska J."/>
</authorList>
<dbReference type="PubMed" id="18804435"/>
<dbReference type="DOI" id="10.1016/j.devcel.2008.08.001"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="26107" last="26115">
<title>Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.</title>
<authorList>
<person name="Saegusa J."/>
<person name="Akakura N."/>
<person name="Wu C.Y."/>
<person name="Hoogland C."/>
<person name="Ma Z."/>
<person name="Lam K.S."/>
<person name="Liu F.T."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="18635536"/>
<dbReference type="DOI" id="10.1074/jbc.m804835200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="183" first="1159" last="1173">
<title>JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation.</title>
<authorList>
<person name="Luissint A.C."/>
<person name="Lutz P.G."/>
<person name="Calderwood D.A."/>
<person name="Couraud P.O."/>
<person name="Bourdoulous S."/>
</authorList>
<dbReference type="PubMed" id="19064666"/>
<dbReference type="DOI" id="10.1083/jcb.200805061"/>
</citation>
<scope>FUNCTION IN LEUKOCYTE TO ENDOTHELIAL CELLS ADHESION</scope>
<scope>INTERACTION WITH JAML</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Virology" volume="370" first="430" last="442">
<title>The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.</title>
<authorList>
<person name="Xiao J."/>
<person name="Palefsky J.M."/>
<person name="Herrera R."/>
<person name="Berline J."/>
<person name="Tugizov S.M."/>
</authorList>
<dbReference type="PubMed" id="17945327"/>
<dbReference type="DOI" id="10.1016/j.virol.2007.09.012"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH EPSTEIN-BARR VIRUS/HHV-4 GB PROTEIN</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212; ASN-481 AND ASN-669</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-406</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-777</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-794</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="10026" last="10037">
<title>The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry.</title>
<authorList>
<person name="Feire A.L."/>
<person name="Roy R.M."/>
<person name="Manley K."/>
<person name="Compton T."/>
</authorList>
<dbReference type="PubMed" id="20660204"/>
<dbReference type="DOI" id="10.1128/jvi.00710-10"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HHV-5 GB</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="43735" last="43747">
<title>ACAP4 protein cooperates with Grb2 protein to orchestrate epidermal growth factor-stimulated integrin beta1 recycling in cell migration.</title>
<authorList>
<person name="Yu X."/>
<person name="Wang F."/>
<person name="Liu H."/>
<person name="Adams G."/>
<person name="Aikhionbare F."/>
<person name="Liu D."/>
<person name="Cao X."/>
<person name="Fan L."/>
<person name="Hu G."/>
<person name="Chen Y."/>
<person name="Frost A."/>
<person name="Partridge E."/>
<person name="Ding X."/>
<person name="Yao X."/>
</authorList>
<dbReference type="PubMed" id="22027826"/>
<dbReference type="DOI" id="10.1074/jbc.m111.278770"/>
</citation>
<scope>INTERACTION WITH ASAP3</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="J. Cell Biol." volume="194" first="307" last="322">
<title>Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition.</title>
<authorList>
<person name="Brunner M."/>
<person name="Millon-Fremillon A."/>
<person name="Chevalier G."/>
<person name="Nakchbandi I.A."/>
<person name="Mosher D."/>
<person name="Block M.R."/>
<person name="Albiges-Rizo C."/>
<person name="Bouvard D."/>
</authorList>
<dbReference type="PubMed" id="21768292"/>
<dbReference type="DOI" id="10.1083/jcb.201007108"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FERMT2 AND TLN1</scope>
<scope>MUTAGENESIS OF VAL-787</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="J. Cell Sci." volume="124" first="879" last="891">
<title>Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins.</title>
<authorList>
<person name="Qu H."/>
<person name="Tu Y."/>
<person name="Shi X."/>
<person name="Larjava H."/>
<person name="Saleem M.A."/>
<person name="Shattil S.J."/>
<person name="Fukuda K."/>
<person name="Qin J."/>
<person name="Kretzler M."/>
<person name="Wu C."/>
</authorList>
<dbReference type="PubMed" id="21325030"/>
<dbReference type="DOI" id="10.1242/jcs.076976"/>
</citation>
<scope>INTERACTION WITH FERMT2</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2012" name="J. Immunol." volume="189" first="5809" last="5819">
<title>Integrins alphavbeta3 and alpha4beta1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.</title>
<authorList>
<person name="Fujita M."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="23125415"/>
<dbReference type="DOI" id="10.4049/jimmunol.1200889"/>
</citation>
<scope>FUNCTION</scope>
<scope>BINDING TO CX3CL1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH CX3CR1 AND CX3CL1</scope>
<scope>CX3CL1-BINDING REGION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-783</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-785 AND THR-789</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-794</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="259" last="271">
<title>Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins alphavbeta3, alpha4beta1, and alpha5beta1.</title>
<authorList>
<person name="Fujita M."/>
<person name="Zhu K."/>
<person name="Fujita C.K."/>
<person name="Zhao M."/>
<person name="Lam K.S."/>
<person name="Kurth M.J."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="25398877"/>
<dbReference type="DOI" id="10.1074/jbc.m114.579946"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E96372" last="E96372">
<title>The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.</title>
<authorList>
<person name="Fujita M."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="24789099"/>
<dbReference type="DOI" id="10.1371/journal.pone.0096372"/>
</citation>
<scope>BINDING TO CX3CL1</scope>
<scope>CX3CL1-BINDING REGION</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2017" name="J. Biol. Chem." volume="292" first="20067" last="20075">
<title>Direct binding to integrins and loss of disulfide linkage in interleukin-1beta (IL-1beta) are involved in the agonistic action of IL-1beta.</title>
<authorList>
<person name="Takada Y.K."/>
<person name="Yu J."/>
<person name="Fujita M."/>
<person name="Saegusa J."/>
<person name="Wu C.Y."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="29030430"/>
<dbReference type="DOI" id="10.1074/jbc.m117.818302"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL1B</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2019" name="J. Immunol." volume="203" first="1383" last="1391">
<title>Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling.</title>
<authorList>
<person name="Takada Y.K."/>
<person name="Yu J."/>
<person name="Shimoda M."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="31331973"/>
<dbReference type="DOI" id="10.4049/jimmunol.1801630"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="28675" last="28685">
<title>Mechanistic insights into regulated cargo binding by ACAP1 protein.</title>
<authorList>
<person name="Bai M."/>
<person name="Pang X."/>
<person name="Lou J."/>
<person name="Zhou Q."/>
<person name="Zhang K."/>
<person name="Ma J."/>
<person name="Li J."/>
<person name="Sun F."/>
<person name="Hsu V.W."/>
</authorList>
<dbReference type="PubMed" id="22645133"/>
<dbReference type="DOI" id="10.1074/jbc.m112.378810"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 758-769 IN COMPLEX WITH ACAP1</scope>
<scope>INTERACTION WITH ACAP1 AND ITGA5</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 760-ARG-ARG-761; 762-GLU--PHE-767 AND 768-LYS-GLU-769</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2012" name="J. Cell Biol." volume="197" first="131" last="140">
<title>Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor.</title>
<authorList>
<person name="Nagae M."/>
<person name="Re S."/>
<person name="Mihara E."/>
<person name="Nogi T."/>
<person name="Sugita Y."/>
<person name="Takagi J."/>
</authorList>
<dbReference type="PubMed" id="22451694"/>
<dbReference type="DOI" id="10.1083/jcb.201111077"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 21-465 IN COMPLEX WITH ANTIBODY; ITGA5 AND RGD PEPTIDE</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-269 AND ASN-406</scope>
<scope>METAL-BINDING SITES</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2013" name="Mol. Cell" volume="49" first="719" last="729">
<title>Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation.</title>
<authorList>
<person name="Liu W."/>
<person name="Draheim K.M."/>
<person name="Zhang R."/>
<person name="Calderwood D.A."/>
<person name="Boggon T.J."/>
</authorList>
<dbReference type="PubMed" id="23317506"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.12.005"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 784-798 IN COMPLEX WITH ITGB1BP1</scope>
<scope>INTERACTION WITH ITGB1BP1</scope>
<scope>MUTAGENESIS OF THR-788; VAL-790; ASN-792 AND TYR-795</scope>
</reference>
<comment type="function">
<text evidence="11 14 20 22 32 37 41 42 43 48 53 55 56 57 58 59">Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. Isoform 2 interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). When associated with alpha-7/beta-1 integrin, regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and RACK1, serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099). ITGA4:ITGB1 and ITGA5:ITGB1 bind to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling (PubMed:29030430). ITGA5:ITGB3 is a receptor for soluble CD40LG and is required for CD40/CD40LG signaling (PubMed:31331973).</text>
</comment>
<comment type="function">
<molecule>Isoform 5</molecule>
<text evidence="10">Isoform 5 displaces isoform 1 in striated muscles.</text>
</comment>
<comment type="function">
<text evidence="63">(Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human echoviruses 1 and 8.</text>
</comment>
<comment type="function">
<text evidence="46">(Microbial infection) Acts as a receptor for Cytomegalovirus/HHV-5.</text>
</comment>
<comment type="function">
<text evidence="39">(Microbial infection) Acts as a receptor for Epstein-Barr virus/HHV-4.</text>
</comment>
<comment type="function">
<text evidence="23">(Microbial infection) Integrin ITGA5:ITGB1 acts as a receptor for Human parvovirus B19.</text>
</comment>
<comment type="function">
<text evidence="24">(Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human rotavirus.</text>
</comment>
<comment type="function">
<text evidence="34">(Microbial infection) Acts as a receptor for Mammalian reovirus.</text>
</comment>
<comment type="function">
<text evidence="13">(Microbial infection) In case of HIV-1 infection, integrin ITGA5:ITGB1 binding to extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.</text>
</comment>
<comment type="subunit">
<text evidence="11 14 15 16 17 18 20 21 22 25 26 27 28 29 31 32 35 37 38 43 47 48 49 50 52 53 54 57 65">Heterodimer of an alpha and a beta subunit. Beta-1 associates with either alpha-1, alpha-2, alpha-3, alpha-4, alpha-5, alpha-6, alpha-7, alpha-8, alpha-9, alpha-10, alpha-11 or alpha-V. ITGA6:ITGB1 is found in a complex with CD9; interaction takes place in oocytes and is involved in sperm-egg fusion (By similarity). Interacts with seprase FAP (seprase); the interaction occurs at the cell surface of invadopodia membrane in a collagen-dependent manner. Binds LGALS3BP and NMRK2, when associated with alpha-7, but not with alpha-5. Interacts with FGR and HCK. Interacts (via the cytoplasmic region) with RAB25 (via the hypervariable C-terminal region). Interacts with RAB21. Interacts with KRT1 in the presence of RACK1 and SRC. Interacts with JAML; integrin alpha-4/beta-1 may regulate leukocyte to endothelial cells adhesion by controlling JAML homodimerization. Interacts with FLNA, FLNB and RANBP9. Isoform 5 interacts with ACE2. Isoform 1 interacts with the C-terminal region of FLNC. Interacts with MYO10. Interacts with DAB2. Interacts with FERMT2; the interaction is inhibited in presence of ITGB1BP1. Interacts with ITGB1BP1 (via C-terminal region); the interaction is a prerequisite for focal adhesion disassembly. Interacts with TLN1; the interaction is prevented by competitive binding of ITGB1BP1. Interacts with ACAP1; required for ITGB1 recycling. Interacts with ASAP3. Isoform 5 interacts with alpha-7A and alpha-7B in adult skeletal muscle. Isoform 5 interacts with alpha-7B in cardiomyocytes of adult heart. Interacts with EMP2; the interaction may be direct or indirect and ITGB1 has a heterodimer form (By similarity). ITGA5:ITGB1 interacts with CCN3. ITGA4:ITGB1 is found in a ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415). ITGA5:ITGB1 interacts with FBN1 (PubMed:12807887, PubMed:17158881). ITGA5:ITGB1 interacts with IL1B (PubMed:29030430). Interacts with MDK (PubMed:15466886). ITGA4:ITGB1 interacts with MDK; this interaction mediates MDK-induced osteoblast cells migration through PXN phosphorylation (PubMed:15466886). ITGA6:ITGB1 interacts with MDK; this interaction mediates MDK-induced neurite-outgrowth (PubMed:15466886).</text>
</comment>
<comment type="subunit">
<text evidence="63">(Microbial infection) Integrin ITGA2:ITGB1 interacts with human echoviruses 1 and 8 capsid proteins.</text>
</comment>
<comment type="subunit">
<text evidence="46">(Microbial infection) Interacts with human cytomegalovirus/HHV-5 envelope glycoprotein B/gB.</text>
</comment>
<comment type="subunit">
<text evidence="39">(Microbial infection) Interacts with Epstein-Barr virus/HHV-4 gB protein.</text>
</comment>
<comment type="subunit">
<text evidence="23">(Microbial infection) Integrin ITGA5:ITGB1 interacts with human parvovirus B19 capsid protein.</text>
</comment>
<comment type="subunit">
<text evidence="24">(Microbial infection) Integrin ITGA2:ITGB1 interacts with human rotavirus VP4 protein.</text>
</comment>
<comment type="subunit">
<text evidence="34">(Microbial infection) Interacts with mammalian reovirus capsid proteins.</text>
</comment>
<comment type="subunit">
<text evidence="13">(Microbial infection) Integrin ITGA5:ITGB1 interacts with HIV-1 Tat.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-78188">
<id>P78536</id>
<label>ADAM17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-2968146">
<id>Q9BY76</id>
<label>ANGPTL4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-9348955">
<id>P03192</id>
<label>BMRF2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-1809771">
<id>P32927</id>
<label>CSF2RB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-15188013">
<id>P78423</id>
<label>CX3CL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-2834630">
<id>P17813</id>
<label>ENG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-704216">
<id>P05413</id>
<label>FABP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-350432">
<id>P21333</id>
<label>FLNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-702960">
<id>P17301</id>
<label>ITGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-703044">
<id>P13612</id>
<label>ITGA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-1382311">
<id>P08648</id>
<label>ITGA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6082935">
<id>P05556-1</id>
</interactant>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-1993555">
<id>P35282</id>
<label>Rab21</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-703066">
<id>P05556</id>
</interactant>
<interactant intactId="EBI-1039593">
<id>P26039</id>
<label>Tln1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7208579">
<id>P05556-5</id>
</interactant>
<interactant intactId="EBI-2255655">
<id>Q71LX4</id>
<label>Tln2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="66">Cell membrane</location>
<topology evidence="12">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cell projection</location>
<location evidence="14">Invadopodium membrane</location>
<topology evidence="12">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="66">Cell projection</location>
<location evidence="66">Ruffle membrane</location>
<topology evidence="12">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Recycling endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="36">Melanosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="40">Cleavage furrow</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cell projection</location>
<location evidence="19">Lamellipodium</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cell projection</location>
<location evidence="19">Ruffle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="37">Cell junction</location>
<location evidence="37">Focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="37">Cell surface</location>
</subcellularLocation>
<text evidence="14 66">Isoform 2 does not localize to focal adhesions. Highly enriched in stage I melanosomes. Located on plasma membrane of neuroblastoma NMB7 cells. In a lung cancer cell line, in prometaphase and metaphase, localizes diffusely at the membrane and in a few intracellular vesicles. In early telophase, detected mainly on the matrix-facing side of the cells. By mid-telophase, concentrated to the ingressing cleavage furrow, mainly to the basal side of the furrow. In late telophase, concentrated to the extending protrusions formed at the opposite ends of the spreading daughter cells, in vesicles at the base of the lamellipodia formed by the separating daughter cells. Colocalizes with ITGB1BP1 and metastatic suppressor protein NME2 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen. Translocates from peripheral focal adhesions sites to fibrillar adhesions in a ITGB1BP1-dependent manner. Enriched preferentially at invadopodia, cell membrane protrusions that correspond to sites of cell invasion, in a collagen-dependent manner. Localized at plasma and ruffle membranes in a collagen-independent manner.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="10">Cell membrane</location>
<location evidence="10">Sarcolemma</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cell junction</location>
</subcellularLocation>
<text evidence="10">In cardiac muscle, isoform 5 is found in costameres and intercalated disks.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P05556-1</id>
<name>1</name>
<name>Beta-1A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P05556-2</id>
<name>2</name>
<name>Beta-1B</name>
<sequence type="described" ref="VSP_002741"/>
</isoform>
<isoform>
<id>P05556-3</id>
<name>3</name>
<name>Beta-1C</name>
<sequence type="described" ref="VSP_002742"/>
</isoform>
<isoform>
<id>P05556-4</id>
<name>4</name>
<name>Beta-1C-2</name>
<sequence type="described" ref="VSP_002743"/>
</isoform>
<isoform>
<id>P05556-5</id>
<name>5</name>
<name>Beta-1D</name>
<sequence type="described" ref="VSP_002744"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="30 51 60 61 62 64">Isoform 1 is widely expressed, other isoforms are generally coexpressed with a more restricted distribution. Isoform 2 is expressed in skin, liver, skeletal muscle, cardiac muscle, placenta, umbilical vein endothelial cells, neuroblastoma cells, lymphoma cells, hepatoma cells and astrocytoma cells. Isoform 3 and isoform 4 are expressed in muscle, kidney, liver, placenta, cervical epithelium, umbilical vein endothelial cells, fibroblast cells, embryonal kidney cells, platelets and several blood cell lines. Isoform 4, rather than isoform 3, is selectively expressed in peripheral T-cells. Isoform 3 is expressed in non-proliferating and differentiated prostate gland epithelial cells and in platelets, on the surface of erythroleukemia cells and in various hematopoietic cell lines. Isoform 5 is expressed specifically in striated muscle (skeletal and cardiac muscle).</text>
</comment>
<comment type="PTM">
<text evidence="10">The cysteine residues are involved in intrachain disulfide bonds.</text>
</comment>
<comment type="similarity">
<text evidence="67">Belongs to the integrin beta chain family.</text>
</comment>
<comment type="sequence caution" evidence="67">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAD97649" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CD29"/>
<text>CD29 entry</text>
</comment>
<dbReference type="EMBL" id="X07979">
<property type="protein sequence ID" value="CAA30790.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291697">
<property type="protein sequence ID" value="BAF84386.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537407">
<property type="protein sequence ID" value="CAD97649.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL365203">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85948.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85949.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85950.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85951.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85952.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85953.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85954.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85955.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85957.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85958.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW85959.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020057">
<property type="protein sequence ID" value="AAH20057.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113901">
<property type="protein sequence ID" value="AAI13902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U33879">
<property type="protein sequence ID" value="AAA79832.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33880">
<property type="protein sequence ID" value="AAA79833.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33879">
<property type="protein sequence ID" value="AAA79833.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33882">
<property type="protein sequence ID" value="AAA79834.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33879">
<property type="protein sequence ID" value="AAA79834.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33881">
<property type="protein sequence ID" value="AAA79834.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33882">
<property type="protein sequence ID" value="AAA79835.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U33879">
<property type="protein sequence ID" value="AAA79835.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34189">
<property type="protein sequence ID" value="AAA59182.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M84237">
<property type="protein sequence ID" value="AAA74402.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M84237">
<property type="protein sequence ID" value="AAA74403.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U28252">
<property type="protein sequence ID" value="AAA81366.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7174.1">
<molecule id="P05556-1"/>
</dbReference>
<dbReference type="PIR" id="B27079">
<property type="entry name" value="B27079"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002202.2">
<molecule id="P05556-1"/>
<property type="nucleotide sequence ID" value="NM_002211.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_391988.1">
<molecule id="P05556-5"/>
<property type="nucleotide sequence ID" value="NM_033668.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_596867.1">
<molecule id="P05556-1"/>
<property type="nucleotide sequence ID" value="NM_133376.2"/>
</dbReference>
<dbReference type="PDB" id="1K11">
<property type="method" value="Model"/>
<property type="chains" value="B=786-797"/>
</dbReference>
<dbReference type="PDB" id="1LHA">
<property type="method" value="Model"/>
<property type="chains" value="A=86-543"/>
</dbReference>
<dbReference type="PDB" id="3G9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.16"/>
<property type="chains" value="C/D=752-785"/>
</dbReference>
<dbReference type="PDB" id="3T9K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=758-769"/>
</dbReference>
<dbReference type="PDB" id="3VI3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B/D=21-465"/>
</dbReference>
<dbReference type="PDB" id="3VI4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B/D=21-465"/>
</dbReference>
<dbReference type="PDB" id="4DX9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="6/7/8/9/B/D/F/H/J/L/N/P/R/T/V/X/Z/b/d/f/h/j/l/n/p/r/t/v/x/z=784-798"/>
</dbReference>
<dbReference type="PDB" id="4WJK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="B=21-465"/>
</dbReference>
<dbReference type="PDB" id="4WK0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="B=21-465"/>
</dbReference>
<dbReference type="PDB" id="4WK2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=21-465"/>
</dbReference>
<dbReference type="PDB" id="4WK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=21-465"/>
</dbReference>
<dbReference type="PDBsum" id="1K11"/>
<dbReference type="PDBsum" id="1LHA"/>
<dbReference type="PDBsum" id="3G9W"/>
<dbReference type="PDBsum" id="3T9K"/>
<dbReference type="PDBsum" id="3VI3"/>
<dbReference type="PDBsum" id="3VI4"/>
<dbReference type="PDBsum" id="4DX9"/>
<dbReference type="PDBsum" id="4WJK"/>
<dbReference type="PDBsum" id="4WK0"/>
<dbReference type="PDBsum" id="4WK2"/>
<dbReference type="PDBsum" id="4WK4"/>
<dbReference type="SMR" id="P05556"/>
<dbReference type="BioGrid" id="109894">
<property type="interactions" value="128"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1794">
<property type="entry name" value="Integrin alpha5-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1797">
<property type="entry name" value="Integrin alpha3-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1798">
<property type="entry name" value="Integrin alpha1-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1801">
<property type="entry name" value="Integrin alpha2-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1802">
<property type="entry name" value="Integrin alpha4-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1803">
<property type="entry name" value="Integrin alpha6-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1804">
<property type="entry name" value="Integrin alpha7-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1815">
<property type="entry name" value="Integrin alpha8-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1816">
<property type="entry name" value="Integrin alpha9-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1817">
<property type="entry name" value="Integrin alpha10-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1818">
<property type="entry name" value="Integrin alpha11-beta1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1819">
<property type="entry name" value="Integrin alphav-beta1 complex"/>
</dbReference>
<dbReference type="CORUM" id="P05556"/>
<dbReference type="DIP" id="DIP-312N"/>
<dbReference type="ELM" id="P05556"/>
<dbReference type="IntAct" id="P05556">
<property type="interactions" value="103"/>
</dbReference>
<dbReference type="MINT" id="P05556"/>
<dbReference type="STRING" id="9606.ENSP00000379350"/>
<dbReference type="BindingDB" id="P05556"/>
<dbReference type="ChEMBL" id="CHEMBL1905"/>
<dbReference type="DrugBank" id="DB00098">
<property type="generic name" value="Antithymocyte immunoglobulin (rabbit)"/>
</dbReference>
<dbReference type="DrugCentral" id="P05556"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2455"/>
<dbReference type="TCDB" id="9.B.87.1.8">
<property type="family name" value="the selenoprotein p receptor (selp-receptor) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1414"/>
<dbReference type="GlyConnect" id="283"/>
<dbReference type="iPTMnet" id="P05556"/>
<dbReference type="PhosphoSitePlus" id="P05556"/>
<dbReference type="SwissPalm" id="P05556"/>
<dbReference type="UniCarbKB" id="P05556"/>
<dbReference type="BioMuta" id="ITGB1"/>
<dbReference type="DMDM" id="218563324"/>
<dbReference type="CPTAC" id="CPTAC-229"/>
<dbReference type="CPTAC" id="CPTAC-230"/>
<dbReference type="EPD" id="P05556"/>
<dbReference type="jPOST" id="P05556"/>
<dbReference type="MassIVE" id="P05556"/>
<dbReference type="MaxQB" id="P05556"/>
<dbReference type="PaxDb" id="P05556"/>
<dbReference type="PeptideAtlas" id="P05556"/>
<dbReference type="PRIDE" id="P05556"/>
<dbReference type="ProteomicsDB" id="51850">
<molecule id="P05556-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51851">
<molecule id="P05556-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51852">
<molecule id="P05556-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51853">
<molecule id="P05556-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51854">
<molecule id="P05556-5"/>
</dbReference>
<dbReference type="ABCD" id="P05556"/>
<dbReference type="Antibodypedia" id="3126">
<property type="antibodies" value="2775 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3688"/>
<dbReference type="Ensembl" id="ENST00000302278">
<molecule id="P05556-1"/>
<property type="protein sequence ID" value="ENSP00000303351"/>
<property type="gene ID" value="ENSG00000150093"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396033">
<molecule id="P05556-1"/>
<property type="protein sequence ID" value="ENSP00000379350"/>
<property type="gene ID" value="ENSG00000150093"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000423113">
<molecule id="P05556-5"/>
<property type="protein sequence ID" value="ENSP00000388694"/>
<property type="gene ID" value="ENSG00000150093"/>
</dbReference>
<dbReference type="GeneID" id="3688"/>
<dbReference type="KEGG" id="hsa:3688"/>
<dbReference type="UCSC" id="uc001iwr.5">
<molecule id="P05556-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3688"/>
<dbReference type="DisGeNET" id="3688"/>
<dbReference type="GeneCards" id="ITGB1"/>
<dbReference type="HGNC" id="HGNC:6153">
<property type="gene designation" value="ITGB1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000150093">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="135630">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P05556"/>
<dbReference type="OpenTargets" id="ENSG00000150093"/>
<dbReference type="PharmGKB" id="PA29953"/>
<dbReference type="eggNOG" id="KOG1226">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XP60">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00980000198506"/>
<dbReference type="HOGENOM" id="CLU_011772_2_1_1"/>
<dbReference type="InParanoid" id="P05556"/>
<dbReference type="KO" id="K05719"/>
<dbReference type="OMA" id="DEQMCTF"/>
<dbReference type="OrthoDB" id="473040at2759"/>
<dbReference type="PhylomeDB" id="P05556"/>
<dbReference type="TreeFam" id="TF105392"/>
<dbReference type="Reactome" id="R-HSA-1566948">
<property type="pathway name" value="Elastic fibre formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1566977">
<property type="pathway name" value="Fibronectin matrix formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202733">
<property type="pathway name" value="Cell surface interactions at the vascular wall"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210991">
<property type="pathway name" value="Basigin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2129379">
<property type="pathway name" value="Molecules associated with elastic fibres"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-216083">
<property type="pathway name" value="Integrin cell surface interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000157">
<property type="pathway name" value="Laminin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000170">
<property type="pathway name" value="Syndecan interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000178">
<property type="pathway name" value="ECM proteoglycans"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416700">
<property type="pathway name" value="Other semaphorin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446343">
<property type="pathway name" value="Localization of the PINCH-ILK-PARVIN complex to focal adhesions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-447041">
<property type="pathway name" value="CHL1 interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75892">
<property type="pathway name" value="Platelet Adhesion to exposed collagen"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8874081">
<property type="pathway name" value="MET activates PTK2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875513">
<property type="pathway name" value="MET interacts with TNS proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="SABIO-RK" id="P05556"/>
<dbReference type="SignaLink" id="P05556"/>
<dbReference type="SIGNOR" id="P05556"/>
<dbReference type="ChiTaRS" id="ITGB1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P05556"/>
<dbReference type="GeneWiki" id="CD29"/>
<dbReference type="GenomeRNAi" id="3688"/>
<dbReference type="Pharos" id="P05556">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P05556"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="P05556">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000150093">
<property type="expression patterns" value="Expressed in visceral pleura and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P05556">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P05556">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005623">
<property type="term" value="C:cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032154">
<property type="term" value="C:cleavage furrow"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030175">
<property type="term" value="C:filopodium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097386">
<property type="term" value="C:glial cell projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099699">
<property type="term" value="C:integral component of synaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034665">
<property type="term" value="C:integrin alpha1-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034680">
<property type="term" value="C:integrin alpha10-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034681">
<property type="term" value="C:integrin alpha11-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034666">
<property type="term" value="C:integrin alpha2-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034667">
<property type="term" value="C:integrin alpha3-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034674">
<property type="term" value="C:integrin alpha5-beta1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034677">
<property type="term" value="C:integrin alpha7-beta1 complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034678">
<property type="term" value="C:integrin alpha8-beta1 complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014704">
<property type="term" value="C:intercalated disc"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071438">
<property type="term" value="C:invadopodium membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035748">
<property type="term" value="C:myelin sheath abaxonal region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031594">
<property type="term" value="C:neuromuscular junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0055037">
<property type="term" value="C:recycling endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0001726">
<property type="term" value="C:ruffle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032587">
<property type="term" value="C:ruffle membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042383">
<property type="term" value="C:sarcolemma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098685">
<property type="term" value="C:Schaffer collateral - CA1 synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050839">
<property type="term" value="F:cell adhesion molecule binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098639">
<property type="term" value="F:collagen binding involved in cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015026">
<property type="term" value="F:coreceptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001968">
<property type="term" value="F:fibronectin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043236">
<property type="term" value="F:laminin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048675">
<property type="term" value="P:axon extension"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030183">
<property type="term" value="P:B cell differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071711">
<property type="term" value="P:basement membrane organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007161">
<property type="term" value="P:calcium-independent cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0055007">
<property type="term" value="P:cardiac muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0023035">
<property type="term" value="P:CD40 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033627">
<property type="term" value="P:cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001708">
<property type="term" value="P:cell fate specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002042">
<property type="term" value="P:cell migration involved in sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030030">
<property type="term" value="P:cell projection organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033631">
<property type="term" value="P:cell-cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007160">
<property type="term" value="P:cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031589">
<property type="term" value="P:cell-substrate adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071404">
<property type="term" value="P:cellular response to low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048813">
<property type="term" value="P:dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000132">
<property type="term" value="P:establishment of mitotic spindle orientation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0021943">
<property type="term" value="P:formation of radial glial scaffolds"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008354">
<property type="term" value="P:germ cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034113">
<property type="term" value="P:heterotypic cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007156">
<property type="term" value="P:homophilic cell adhesion via plasma membrane adhesion molecules"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030032">
<property type="term" value="P:lamellipodium assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007159">
<property type="term" value="P:leukocyte cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050901">
<property type="term" value="P:leukocyte tethering or rolling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048333">
<property type="term" value="P:mesodermal cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000811">
<property type="term" value="P:negative regulation of anoikis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045596">
<property type="term" value="P:negative regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035024">
<property type="term" value="P:negative regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010763">
<property type="term" value="P:positive regulation of fibroblast migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051951">
<property type="term" value="P:positive regulation of glutamate uptake involved in transmission of nerve impulse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000273">
<property type="term" value="P:positive regulation of signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090303">
<property type="term" value="P:positive regulation of wound healing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0150103">
<property type="term" value="P:reactive gliosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031623">
<property type="term" value="P:receptor internalization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010710">
<property type="term" value="P:regulation of collagen catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901979">
<property type="term" value="P:regulation of inward rectifier potassium channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0150003">
<property type="term" value="P:regulation of spontaneous synaptic transmission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045214">
<property type="term" value="P:sarcomere organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP01748"/>
<dbReference type="Gene3D" id="3.40.50.410">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013111">
<property type="entry name" value="EGF_extracell"/>
</dbReference>
<dbReference type="InterPro" id="IPR040622">
<property type="entry name" value="I-EGF_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR027071">
<property type="entry name" value="Integrin_beta-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR033760">
<property type="entry name" value="Integrin_beta_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR015812">
<property type="entry name" value="Integrin_bsu"/>
</dbReference>
<dbReference type="InterPro" id="IPR014836">
<property type="entry name" value="Integrin_bsu_cyt_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR012896">
<property type="entry name" value="Integrin_bsu_tail"/>
</dbReference>
<dbReference type="InterPro" id="IPR036349">
<property type="entry name" value="Integrin_bsu_tail_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002369">
<property type="entry name" value="Integrin_bsu_VWA"/>
</dbReference>
<dbReference type="InterPro" id="IPR032695">
<property type="entry name" value="Integrin_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016201">
<property type="entry name" value="PSI"/>
</dbReference>
<dbReference type="InterPro" id="IPR036465">
<property type="entry name" value="vWFA_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10082">
<property type="entry name" value="PTHR10082"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10082:SF28">
<property type="entry name" value="PTHR10082:SF28"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07974">
<property type="entry name" value="EGF_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18372">
<property type="entry name" value="I-EGF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08725">
<property type="entry name" value="Integrin_b_cyt"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07965">
<property type="entry name" value="Integrin_B_tail"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00362">
<property type="entry name" value="Integrin_beta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17205">
<property type="entry name" value="PSI_integrin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002512">
<property type="entry name" value="Integrin_B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01186">
<property type="entry name" value="INTEGRINB"/>
</dbReference>
<dbReference type="SMART" id="SM00187">
<property type="entry name" value="INB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01241">
<property type="entry name" value="Integrin_b_cyt"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01242">
<property type="entry name" value="Integrin_B_tail"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00423">
<property type="entry name" value="PSI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53300">
<property type="entry name" value="SSF53300"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69179">
<property type="entry name" value="SSF69179"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69687">
<property type="entry name" value="SSF69687"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00022">
<property type="entry name" value="EGF_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00243">
<property type="entry name" value="INTEGRIN_BETA"/>
<property type="match status" value="3"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0401">Integrin</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Integrin beta-1" id="PRO_0000016334">
<location>
<begin position="21"/>
<end position="798"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="21"/>
<end position="728"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="12">
<location>
<begin position="729"/>
<end position="751"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="752"/>
<end position="798"/>
</location>
</feature>
<feature type="domain" description="VWFA">
<location>
<begin position="140"/>
<end position="378"/>
</location>
</feature>
<feature type="repeat" description="I">
<location>
<begin position="466"/>
<end position="515"/>
</location>
</feature>
<feature type="repeat" description="II">
<location>
<begin position="516"/>
<end position="559"/>
</location>
</feature>
<feature type="repeat" description="III">
<location>
<begin position="560"/>
<end position="598"/>
</location>
</feature>
<feature type="repeat" description="IV">
<location>
<begin position="599"/>
<end position="635"/>
</location>
</feature>
<feature type="region of interest" description="CX3CL1-binding" evidence="53">
<location>
<begin position="207"/>
<end position="213"/>
</location>
</feature>
<feature type="region of interest" description="CX3CL1-binding" evidence="55">
<location>
<begin position="295"/>
<end position="314"/>
</location>
</feature>
<feature type="region of interest" description="Cysteine-rich tandem repeats">
<location>
<begin position="466"/>
<end position="635"/>
</location>
</feature>
<feature type="region of interest" description="Signal for sorting from recycling endosomes; interaction with ACAP1">
<location>
<begin position="762"/>
<end position="767"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ITGB1BP1">
<location>
<begin position="785"/>
<end position="792"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium">
<location>
<position position="152"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen">
<location>
<position position="154"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1">
<location>
<position position="156"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1">
<location>
<position position="157"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="189"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="244"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="246"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen">
<location>
<position position="248"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="249"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium">
<location>
<position position="249"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen">
<location>
<position position="362"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="777"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="783"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="785"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="789"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="794"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="50"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="94"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="97"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44">
<location>
<position position="212"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="50">
<location>
<position position="269"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="363"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="33 45 50">
<location>
<position position="406"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="417"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44">
<location>
<position position="481"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="520"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="584"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44">
<location>
<position position="669"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="27"/>
<end position="45"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="35"/>
<end position="464"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="38"/>
<end position="64"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="48"/>
<end position="75"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="207"/>
<end position="213"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="261"/>
<end position="301"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="401"/>
<end position="415"/>
</location>
</feature>
<feature type="disulfide bond" evidence="50">
<location>
<begin position="435"/>
<end position="462"/>
</location>
</feature>
<feature type="disulfide bond" evidence="68">
<location>
<begin position="466"/>
<end position="691"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="477"/>
<end position="489"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="486"/>
<end position="525"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="491"/>
<end position="500"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="502"/>
<end position="516"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="531"/>
<end position="536"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="533"/>
<end position="568"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="538"/>
<end position="553"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="555"/>
<end position="560"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="574"/>
<end position="579"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="576"/>
<end position="607"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="581"/>
<end position="590"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="592"/>
<end position="599"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="613"/>
<end position="618"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="615"/>
<end position="661"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="620"/>
<end position="630"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="633"/>
<end position="636"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="640"/>
<end position="649"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="646"/>
<end position="723"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="665"/>
<end position="699"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="9">
<location>
<position position="794"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002741" evidence="67">
<original>GENPIYKSAVTTVVNPKYEGK</original>
<variation>VSYKTSKKQSGL</variation>
<location>
<begin position="778"/>
<end position="798"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002742" evidence="67">
<original>GENPIYKSAVTTVVNPKYEGK</original>
<variation>SLSVAQPGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP</variation>
<location>
<begin position="778"/>
<end position="798"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002743" evidence="67">
<original>GENPIYKSAVTTVVNPKYEGK</original>
<variation>PGVQWCDISSLQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP</variation>
<location>
<begin position="778"/>
<end position="798"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_002744" evidence="67">
<original>GENPIYKSAVTTVVNPKYEGK</original>
<variation>QENPIYKSPINNFKNPNYGRKAGL</variation>
<location>
<begin position="778"/>
<end position="798"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with ACAP1." evidence="52">
<original>RR</original>
<variation>AA</variation>
<location>
<begin position="760"/>
<end position="761"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces interaction with ACAP1 and ability to recycle; does not affect heterodimerization with ITGA5." evidence="52">
<original>EFAKFE</original>
<variation>AAAAAA</variation>
<location>
<begin position="762"/>
<end position="767"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces interaction with ACAP1.">
<original>EF</original>
<variation>AA</variation>
<location>
<begin position="762"/>
<end position="763"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with ACAP1.">
<original>K</original>
<variation>A</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces interaction with ACAP1.">
<original>FE</original>
<variation>AA</variation>
<location>
<begin position="766"/>
<end position="767"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with ACAP1." evidence="52">
<original>KE</original>
<variation>AA</variation>
<location>
<begin position="768"/>
<end position="769"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of beta-1A interaction with FLNA and FLNB." evidence="17">
<original>G</original>
<variation>Q</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not interact with ITGB1BP1." evidence="18">
<original>AVTTVV</original>
<variation>PINNFK</variation>
<location>
<begin position="786"/>
<end position="791"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of beta-1A interaction with FLNA and FLNB." evidence="17">
<original>A</original>
<variation>P</variation>
<location>
<position position="786"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with ITGB1BP1, but not with FERMT2 or TLN1. Inhibits fibronectin deposition and mineralized bone nodules formation." evidence="48">
<original>V</original>
<variation>T</variation>
<location>
<position position="787"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces ITGB1BP1 binding; when associated with D-790." evidence="54">
<original>T</original>
<variation>D</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces ITGB1BP1 binding; when associated with D-788." evidence="54">
<original>V</original>
<variation>D</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces ITGB1BP1 binding; when associated with A-795." evidence="54">
<original>N</original>
<variation>A</variation>
<location>
<position position="792"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces ITGB1BP1 binding; when associated with A-792." evidence="54">
<original>Y</original>
<variation>A</variation>
<location>
<position position="795"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA30790." ref="1" evidence="67">
<original>T</original>
<variation>H</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA30790." ref="1" evidence="67">
<original>S</original>
<variation>T</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAI13902." ref="6" evidence="67">
<original>CGSLI</original>
<variation>VWMLL</variation>
<location>
<begin position="261"/>
<end position="265"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAI13902." ref="6" evidence="67">
<original>EN</original>
<variation>DG</variation>
<location>
<begin position="385"/>
<end position="386"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAF84386." ref="2" evidence="67">
<original>E</original>
<variation>V</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="26"/>
<end position="31"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="45"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="86"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="118"/>
<end position="124"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="129"/>
<end position="136"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="143"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="153"/>
<end position="155"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="156"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="165"/>
<end position="173"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="180"/>
<end position="187"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="200"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="218"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="229"/>
<end position="236"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="245"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="262"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="269"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="287"/>
<end position="291"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="311"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="319"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="331"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="342"/>
<end position="351"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="352"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="362"/>
<end position="364"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="367"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="382"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="393"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="406"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="409"/>
<end position="413"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="423"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="437"/>
<end position="439"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="441"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="454"/>
<end position="461"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="752"/>
<end position="769"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="770"/>
<end position="772"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G9W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WJK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WK0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WK4"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09055"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10397733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10455171"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10613898"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11741838"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11807098"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11807099"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11919189"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12473654"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12695522"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12807887"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12907437"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12941907"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722085"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15156152"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15181153"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15276642"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15466886"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1551917"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16076904"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16256741"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16501085"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16754960"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081065"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17158881"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17925226"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17945327"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17956333"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18635536"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18804435"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19064666"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20660204"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21325030"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21768292"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22027826"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22451694"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2249781"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22645133"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23125415"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23317506"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24789099"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25398877"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29030430"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31331973"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7523423"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7544298"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7545396"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7681433"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8411387"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9494094"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9501082"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10455171"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000305"/>
<evidence key="68" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22451694"/>
</source>
</evidence>
<sequence length="798" mass="88415" checksum="DE35979C1625578C" modified="2008-12-16" version="2" precursor="true">MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGECIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDIENPRGSKDIKKNKNVTNRSKGTAEKLKPEDITQIQPQQLVLRLRSGEPQTFTLKFKRAEDYPIDLYYLMDLSYSMKDDLENVKSLGTDLMNEMRRITSDFRIGFGSFVEKTVMPYISTTPAKLRNPCTSEQNCTSPFSYKNVLSLTNKGEVFNELVGKQRISGNLDSPEGGFDAIMQVAVCGSLIGWRNVTRLLVFSTDAGFHFAGDGKLGGIVLPNDGQCHLENNMYTMSHYYDYPSIAHLVQKLSENNIQTIFAVTEEFQPVYKELKNLIPKSAVGTLSANSSNVIQLIIDAYNSLSSEVILENGKLSEGVTISYKSYCKNGVNGTGENGRKCSNISIGDEVQFEISITSNKCPKKDSDSFKIRPLGFTEEVEVILQYICECECQSEGIPESPKCHEGNGTFECGACRCNEGRVGRHCECSTDEVNSEDMDAYCRKENSSEICSNNGECVCGQCVCRKRDNTNEIYSGKFCECDNFNCDRSNGLICGGNGVCKCRVCECNPNYTGSACDCSLDTSTCEASNGQICNGRGICECGVCKCTDPKFQGQTCEMCQTCLGVCAEHKECVQCRAFNKGEKKDTCTQECSYFNITKVESRDKLPQPVQPDPVSHCKEKDVDDCWFYFTYSVNGNNEVMVHVVENPECPTGPDIIPIVAGVVAGIVLIGLALLLIWKLLMIIHDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>